Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 276186, 8 pages
http://dx.doi.org/10.1155/2013/276186
Research Article

Changes in the Mucus Barrier during Cisplatin-Induced Intestinal Mucositis in Rats

1Department of Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan
2Department of Regulation Biochemistry, Kitasato University Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan

Received 22 August 2013; Revised 26 November 2013; Accepted 26 November 2013

Academic Editor: Panagiotis Tsirigotis

Copyright © 2013 Hajime Yamamoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Elting, C. Cooksley, M. Chambers, S. B. Cantor, E. Manzullo, and E. B. Rubenstein, “The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis,” Cancer, vol. 98, no. 7, pp. 1531–1539, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. E. Slavin, M. A. Dias, and R. Saral, “Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients,” Cancer, vol. 42, no. 4, pp. 1747–1759, 1978. View at Google Scholar · View at Scopus
  3. E. B. Rubenstein, D. E. Peterson, M. Schubert et al., “Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis,” Cancer, vol. 100, no. 9, pp. 2026–2046, 2004. View at Google Scholar · View at Scopus
  4. S. Sartori, L. Trevisani, I. Nielsen, D. Tassinari, and V. Abbasciano, “Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury,” Cancer, vol. 78, pp. 1447–1482, 1996. View at Google Scholar
  5. S. Sartori, L. Trevisani, I. Nielsen, D. Tassinari, I. Panzini, and V. Abbasciano, “Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury,” Journal of Clinical Oncology, vol. 18, no. 3, pp. 463–467, 2000. View at Google Scholar · View at Scopus
  6. S. T. Sonis, L. S. Elting, D. Keefe et al., “Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients,” Cancer, vol. 100, no. 9, pp. 1995–2025, 2004. View at Google Scholar · View at Scopus
  7. T. Ichikawa, K. Hotta, and K. Ishihara, “Second-generation histamine H2-receptor antagonists with gastric mucosal defensive properties,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 5, pp. 581–589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. D. Homesley, J. M. Gainey, V. W. Jobson, C. E. Welander, H. B. Muss, and H. B. Wells, “Cisplatin chemotherapy and emesis in patients given metoclopramide and controls,” The New England Journal of Medicine, vol. 307, pp. 250–251, 1982. View at Google Scholar
  9. P. J. Hesketh and D. R. Gandara, “Serotonin antagonists: a new class of antiemetic agents,” Journal of the National Cancer Institute, vol. 83, no. 9, pp. 613–620, 1991. View at Google Scholar · View at Scopus
  10. D. Korenaga, M. Honda, M. Yasuda, S. Inutsuka, T. Nozoe, and H. Tashiro, “Increased intestinal permeability correlates with gastrointestinal toxicity among formulations of the fluorouracil analogue tegafur in rats,” European Surgical Research, vol. 34, no. 5, pp. 351–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. D. M. Pritchard, C. S. Potten, and J. A. Hickman, “The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia,” Cancer Research, vol. 58, no. 23, pp. 5453–5465, 1998. View at Google Scholar · View at Scopus
  12. Y. Saegusa, T. Ichikawa, T. Iwai et al., “Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis,” Scandinavian Journal of Gastroenterology, vol. 43, no. 5, pp. 531–537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. M. Vickers, K. Rose, R. Fisher, M. Saulnier, P. Sahota, and P. Bentley, “Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology,” Toxicologic Pathology, vol. 32, no. 5, pp. 577–590, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Singh, “A possible cellular mechanism of cisplatin-induced nephrotoxicity,” Toxicology, vol. 58, no. 1, pp. 71–80, 1989. View at Google Scholar · View at Scopus
  15. Y. Azuumi, S. Ohara, K. Ishihara, H. Okabe, and K. Hotta, “Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats,” Gut, vol. 21, no. 6, pp. 533–536, 1980. View at Google Scholar · View at Scopus
  16. T. Ichikawa, K. Ishihara, Y. Komuro, Y. Kojima, K. Saigenji, and K. Hotta, “Effects of the new histamine H2 receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage,” Life Sciences, vol. 54, no. 10, pp. 159–164, 1994. View at Google Scholar · View at Scopus
  17. Y. Kojima, K. Ishihara, S. Ohara, K. Saigenji, and K. Hotta, “Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage,” Scandinavian Journal of Gastroenterology, vol. 27, no. 9, pp. 764–768, 1992. View at Google Scholar · View at Scopus
  18. Y. Saegusa, T. Ichikawa, T. Iwai et al., “Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis,” Scandinavian Journal of Gastroenterology, vol. 43, no. 1, pp. 59–65, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Ishihara, M. Kurihara, Y. Goso, H. Ota, T. Katsuyama, and K. Hotta, “Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa,” Glycoconjugate Journal, vol. 13, no. 5, pp. 857–864, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Tsubokawa, Y. Goso, A. Sawaguchi et al., “A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin: analysis of the epitope sequence and immunohistochemical study,” FEBS Journal, vol. 274, no. 7, pp. 1833–1848, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Ota and T. Katsuyama, “Alternating laminated array of two types of mucin in the human gastric surface mucous layer,” Histochemical Journal, vol. 24, no. 2, pp. 86–92, 1992. View at Google Scholar · View at Scopus
  22. J. Gerdes, H. Lemke, H. Baisch, H. H. Wacker, U. Schwab, and H. Stein, “Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67,” Journal of Immunology, vol. 133, no. 4, pp. 1710–1715, 1984. View at Google Scholar · View at Scopus
  23. C. Gerlach, M. Golding, L. Larue, M. R. Alison, and J. Gerdes, “Ki-67 immunoexpression is a robust marker of proliferative cells in the rat,” Laboratory Investigation, vol. 77, no. 6, pp. 697–698, 1997. View at Google Scholar · View at Scopus
  24. C. Gerlach, D. Y. Sakkab, T. Scholzen, R. Daßler, M. R. Alison, and J. Gerdes, “Ki-67 expression during rat liver regeneration after partial hepatectomy,” Hepatology, vol. 26, no. 3, pp. 573–578, 1997. View at Google Scholar · View at Scopus
  25. Y. Tazuke, K. Maeda, M. Wasa, N. Satoko, and M. Fukuzawa, “Protective mechanism of glutamine on the expression of proliferating cell nuclear antigen after cisplatin-induced intestinal mucosal injury,” Pediatric Surgery International, vol. 27, no. 2, pp. 151–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Miyamoto and M. Miyamoto, “Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment,” Experimental and Molecular Pathology, vol. 77, no. 3, pp. 238–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Miyamoto and M. Miyamoto, “Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment,” Experimental and Molecular Pathology, vol. 77, no. 3, pp. 238–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ichikawa, H. Ota, A. Sugiyama et al., “Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa,” Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 1800–1805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. V. L. Bodiga, S. Bodiga, S. Surampudi et al., “Effect of vitamin supplementation on cisplatin-induced intestinal epithelial cell apoptosis in Wistar/NIN rats,” Nutrition, vol. 28, no. 5, pp. 572–580, 2012. View at Publisher · View at Google Scholar · View at Scopus